Data on IL-6 c.-174 G>C genotype and allele frequencies in patients with coronary heart disease in dependence of cardiovascular outcome

Stefan Reichert, Axel Schlitt, Ann-Christin Benten, Britt Hofmann, Hans-Günter Schaller, Susanne Schulz, Stefan Reichert, Axel Schlitt, Ann-Christin Benten, Britt Hofmann, Hans-Günter Schaller, Susanne Schulz

Abstract

In this data article we present data on the distribution of alleles and genotypes of the interleukin (IL)-6 c.-174 G>C polymorphism (rs 1800795) in patients with coronary heart disease (CHD) in dependence of the incidence of new cardiovascular events (combined endpoint: myocardial infarction, stroke/TIA, cardiac death, death according to stroke) within three years follow-up. Moreover, we investigated putative associations between individual expression of IL-6 genotypes and IL-6 serum level. This investigation is a subanalysis of the article entitled "The Interleukin 6 c.-174 CC genotype is a predictor for new cardiovascular events in patients with coronary heart disease within three years follow-up" (ClinicalTrials.gov identifier: NCT01045070) (Reichert et al., 2016) [1].

Keywords: Coronary heart disease; IL-6 polymorphism; IL-6 serum level; New cardiovascular events.

Figures

Fig. 1
Fig. 1
Boxplots of IL-6 serum levels in dependence of the individual expression of the IL-6 c.-174 G>C genotypes GG, CG and CC. Statistical comparison was made with Kruskal–Wallis test.

References

    1. Reichert S., Schlitt A., Benten A.C., Hofmann B., Schaller H.G., Schulz S. The interleukin 6 c.−174 CC genotype is a predictor for new cardiovascular events in patients with coronary heart disease within three years follow-up. Cytokine. 2016;83:136–138.
    1. Patterson C.C., Blankenberg S., Ben-Shlomo Y. Which biomarkers are predictive specifically for cardiovascular or for non-cardiovascular mortality in men? Evidence from the Caerphilly Prospective Study (CaPS) Int. J. Cardiol. 2015;201:113–118.
    1. Bao P., Liu G., Wei Y. Association between IL-6 and related risk factors of metabolic syndrome and cardiovascular disease in young rats. Int. J. Clin. Exp. Med. 2015;8:13491–13499.
    1. Tehrani D.M., Wong N.D. Cardiovascular disease risk assessment: review of established and newer modalities. Curr. Treat. Options Cardiovasc. Med. 2015;17:57.

Source: PubMed

3
구독하다